Dignitana and Konica Minolta collaborate on innovative scalp cooling technology

Dignitana, a leading provider of innovative medical devices, has teamed up with Konica Minolta, a renowned technology company, to introduce the DigniCap Scalp Cooling System in Japan. This collaboration aims to help cancer patients reduce hair loss caused by chemotherapy through the use of the advanced DigniCap Delta device. The Ministry of Health, Labor and Welfare in Japan has granted market approval for this groundbreaking technology, with an initial sale of five devices to Konica Minolta scheduled for June.

The partnership between Dignitana and Konica Minolta marks a significant milestone in bringing cutting-edge scalp cooling technology to cancer centers across Japan. By leveraging Konica Minolta's expertise and market access, both companies are dedicated to enhancing the quality of life for cancer patients in the region.

With over one million new cancer cases reported annually in Japan, the need for effective solutions like the DigniCap Delta device is crucial, especially for patients undergoing chemotherapy for solid tumors such as breast, ovarian, and prostate cancer. This FDA-cleared device utilizes state-of-the-art thermoelectric cooling to minimize chemotherapy-induced hair loss, aligning with clinical practice guidelines recommended by leading organizations worldwide.

The collaboration between Dignitana and Konica Minolta aims to meet the rising demand for scalp cooling technology in Japan and provide patients with access to innovative solutions for managing the side effects of cancer treatment. By joining forces, these companies are paving the way for improved care and support for cancer patients in the country.